We continue to invest heavily to meet our client's growth goals. These investments have included headcount increases, travel primarily related to Discover, increased clinical costs at off-campus classroom and laboratory sites due to the nursing shortage, technology services both in headcount and license fees as a result of new technology requests by our partners, and costs related to the new hybrid locations as we open five sites in the year ended December 31st, 2023, four sites in the six months added June 30th, 2024, and more will open later in 2024.

Aug 6, 2024 / receipt, needs a key / Dan Backus, CFO | earnings call 2024-08-06 | transcript 1bb008f2-2c3e-4c7e-acd3-5f4e9e7361b8 | chars 19745-20303 | segment 19

On the expense side, as you will recall, we made significant investments in the past few years, primarily in headcount and travel expenses to meet the growth goals of our partners.

Aug 6, 2024 / receipt, needs a key / CFO, CFO | earnings call 2024-08-06 | transcript 1bb008f2-2c3e-4c7e-acd3-5f4e9e7361b8 | chars 26907-27087 | segment 27

These investments include headcount increases, travel primarily related to Discover, increased clinical costs at off-campus classroom and laboratory sites due to the nursing shortage, technology services both in headcount and licensees fees as a result of new technology requests by our partners and costs related to the new hybrid locations as we opened five sites and the year ended December 31st, 2023.

May 7, 2024 / receipt, needs a key / Dan Backus, CFO | earnings call 2024-05-07 | transcript 1d19f4e7-7a28-426a-a9b3-a853b8986795 | chars 17406-17811 | segment 17

On the expense side, as you recall, we made significant investments in the past few years, primarily in headcount and travel expenses to meet our growth goals of our partners.

May 7, 2024 / receipt, needs a key / Brian Mueller, CEO | earnings call 2024-05-07 | transcript 1d19f4e7-7a28-426a-a9b3-a853b8986795 | chars 22143-22318 | segment 22

These investments include headcount increases, travel primarily related to Discover, increased clinical costs at off-campus classroom and laboratory sites due to the nursing shortage, technology services both in headcount and licensees fees as a result of new technology requests by our partners, and costs related to the new hybrid locations as we opened five sites and the year ended December 31st, 2023.

May 7, 2024 / receipt, needs a key / Dan Backus, CFO | earnings call 2024-05-07 | transcript 1d19f4e7-7a28-426a-a9b3-a853b8986795 | chars 51901-52307 | segment 52